A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With Sarcopenia
NCT07668180
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Sarcopenia in Elderly
Interventions
DRUG:
IN-207907 120 mg
DRUG:
IN-207907 240 mg
DRUG:
IN-207907 360 mg
DRUG:
Placebo
Sponsor
HK inno.N Corporation